Also, as previously indicated...we have broken every level of technical support there is (the only thing remaining is the 100 day moving average at $5.44). I'm "hoping" the last 2 trading days are the beginning of it finding some footing in the $5.80-$5.90 range, but there is no way for me to guarantee that. The stock is way oversold too, but it remained oversold for several months back in September-November before finally breaking free. Technicals are a guide, not a certainty.
Lastly, the company just said last Tuesday that information on next steps with Drisapersen would not be released until sometime in Q2. Based on this, one can surmise that if their 120 day wind-down period with GSK started on 1/12/14...that the likelihood of that info coming before 5/12/14 is slim-to-none.
That means, you've got a long road ahead until any further "big news". So, I suggest if you are that worried you sell the stock, take your lumps and move on. This is a biotech stock. It's highly volatile, highly speculative and not for the faint of heart. GL.
Recent RNA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 08:07:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/21/2024 08:05:00 PM
- Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day • PR Newswire (US) • 06/20/2024 01:00:00 PM
- Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 06/17/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:06:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:58:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:56:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:58:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/14/2024 08:10:22 PM
- Avidity Biosciences to Participate in Upcoming Investor Conference • PR Newswire (US) • 06/14/2024 01:00:00 PM
- Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock • PR Newswire (US) • 06/14/2024 12:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/13/2024 08:26:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/12/2024 08:22:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/12/2024 08:19:05 PM
- Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock • PR Newswire (US) • 06/12/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 11:02:29 AM
- Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes and Trends of Functional Improvement in People Living with Facioscapulohumeral Muscular Dystrophy • PR Newswire (US) • 06/12/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:46:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:27:15 PM
- Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in People Living with Facioscapulohumeral Muscular Dystrophy at 31st Annual FSHD Society International Research Congress • PR Newswire (US) • 05/29/2024 08:05:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/21/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 10:21:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 10:15:29 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM